Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 234, Issue 4, Pages 3238-3253
Publisher
Wiley
Online
2018-10-14
DOI
10.1002/jcp.26768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines
- (2017) Rana Jahanban-Esfahlan et al. GENE
- Multiple Functions of Long Non-Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer Progression
- (2017) Sadra Samavarchi Tehrani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Modulating tumor hypoxia by nanomedicine for effective cancer therapy
- (2017) Rana Jahanban-Esfahlan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways
- (2017) Maryam Majidinia et al. JOURNAL OF PINEAL RESEARCH
- STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer
- (2017) Luwei Wei et al. MEDICINE
- Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
- (2017) Yi Kan Wang et al. NATURE GENETICS
- Biocompatible magnetic tris(2-aminoethyl)amine functionalized nanocrystalline cellulose as a novel nanocarrier for anticancer drug delivery of methotrexate
- (2017) Mahdi Rahimi et al. NEW JOURNAL OF CHEMISTRY
- Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
- (2017) Shan Deng et al. Oncotarget
- Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
- (2017) Hyun Hee Lee et al. PLoS One
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
- (2016) Bahman Yousefi et al. Anti-Cancer Agents in Medicinal Chemistry
- The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis
- (2016) Luyang Zhao et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
- (2016) Jin-Gyoung Jung et al. CANCER RESEARCH
- DNA damage response regulation by microRNAs as a therapeutic target in cancer
- (2016) Maryam Majidinia et al. DNA REPAIR
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
- (2016) Radosſaw Januchowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
- (2016) Lan G. Coffman et al. Oncotarget
- Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer
- (2016) Tasuku Mariya et al. Oncotarget
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Anti-Proliferative Properties of Cornus mass Fruit in Different Human Cancer Cells
- (2015) Bahman Yousefi et al. Asian Pacific Journal of Cancer Prevention
- Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer
- (2015) Minal Garg EXPERT OPINION ON THERAPEUTIC TARGETS
- Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
- (2015) Claire Bonneau et al. GYNECOLOGIC ONCOLOGY
- Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy
- (2015) Irena Conic et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells
- (2015) Amit Kumar Srivastava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
- (2015) Haixia Long et al. Oncotarget
- Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells
- (2015) Yi-Hui Wu et al. Journal of Cancer
- Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture
- (2014) Junsong Chen et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- The origin of cancer stem cells
- (2014) Hien T. Dang et al. JOURNAL OF HEPATOLOGY
- p53 protein aggregation promotes platinum resistance in ovarian cancer
- (2014) Y Yang-Hartwich et al. ONCOGENE
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
- (2014) Erhong Meng et al. PLoS One
- CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype
- (2013) Kyu Sub Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells
- (2013) Mi Kwon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
- (2013) Nuzhat Ahmed et al. MOLECULAR ASPECTS OF MEDICINE
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Susceptibility of CD24+ ovarian cancer cells to anti-cancer drugs and natural killer cells
- (2012) Jiae Koh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
- (2012) My Wintzell et al. BMC CANCER
- Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
- (2012) My Wintzell et al. CANCER BIOLOGY & THERAPY
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype
- (2012) Francesca Ricci et al. CELL CYCLE
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- The role of epigenetic regulation in stem cell and cancer biology
- (2012) Lilian E. van Vlerken et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EpCAM and its potential role in tumor-initiating cells
- (2012) Sannia Imrich et al. Cell Adhesion & Migration
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Stem Cell Quiescence
- (2011) L. Li et al. CLINICAL CANCER RESEARCH
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
- (2011) Gilbert Spizzo et al. JOURNAL OF CLINICAL PATHOLOGY
- CD133 expression associated with poor prognosis in ovarian cancer
- (2011) Jing Zhang et al. MODERN PATHOLOGY
- Isolation and characterization of stem-like cells from a human ovarian cancer cell line
- (2011) Lijuan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
- (2011) Neeraj Lalwani et al. RADIOGRAPHICS
- Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction
- (2011) Eike Gallmeier et al. STEM CELLS
- Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
- (2010) Li Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate
- (2010) Bin Zhang et al. CANCER CELL
- MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
- (2010) N. Gaspar et al. CANCER RESEARCH
- Targeting Hypoxic Cells through the DNA Damage Response
- (2010) M. Olcina et al. CLINICAL CANCER RESEARCH
- Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
- (2010) T Kato et al. GENE THERAPY
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
- (2010) X. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human ovarian cancer stem cells
- (2010) Sharmila A Bapat REPRODUCTION
- CD133 antigen expression in ovarian cancer
- (2009) Gabriella Ferrandina et al. BMC CANCER
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- ABCG2: the key to chemoresistance in cancer stem cells?
- (2009) Yi An et al. Expert Opinion on Drug Metabolism & Toxicology
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
- (2008) Markus Munz Frontiers in Bioscience-Landmark
- Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
- (2008) Russell J. Schilder et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now